Conclusion:
This case describes an unusual presentation of AGEP following
COVID-19, which stresses the complexity of the association between AGEP
and COVID-19, implicating not only drug intake but also the impact of
SARSCoV2 on the immune system and the cytokine storm induced by this
infection.